Chronic kidney disease (CKD) and heart failure affect many people worldwide. Despite the
availability of pharmacological treatments, both diseases remain associated with …

Heart failure (HF) is one of the greatest problems in healthcare and it often coexists with
declining renal function. The pathophysiology between the heart and the kidneys is …

Background Guidelines recommend early initiation of multiple guideline-directed medical
therapies (GDMTs) to reduce mortality/rehospitalization in patients with heart failure and …

In modern cardiology, sodium‐glucose cotransporter 2 (SGLT2) inhibitors are critical
components of heart failure (HF) treatment algorithms and exert their effects primarily by …

Diabetic kidney disease (DKD) is emerging rapidly as the leading cause of chronic kidney
disease (CKD) worldwide. In this 3-year prospective, multicenter cohort study, a total of 1138 …

The syndrome of heart failure (HF) has historically been dichotomized based on clinical trial
inclusion criteria into patients with a reduced or preserved left ventricular ejection fraction …

Diabetic kidney disease (DKD) is one of the most important comorbidities for patients with
diabetes, and its incidence has exceeded one tenth, with an increasing trend. Studies have …

The burden of heart failure among people with type 2 diabetes is increasing globally. People
with comorbid type 2 diabetes and heart failure often have worse outcomes than those with …

Obesity is a serious chronic disease and an independent risk factor for the new onset and
progression of chronic kidney disease (CKD). CKD prevalence is expected to increase, at …

Chronic kidney disease (CKD) is a risk factor for premature cardiovascular disease. As
kidney function declines, the presence of left ventricular abnormalities increases such that …